These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2043574)

  • 1. Use of orbital floor steroids in the management of patients with uniocular non-necrotising scleritis.
    Hakin KN; Ham J; Lightman SL
    Br J Ophthalmol; 1991 Jun; 75(6):337-9. PubMed ID: 2043574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cyclosporin in the management of steroid dependent non-necrotising scleritis.
    Hakin KN; Ham J; Lightman SL
    Br J Ophthalmol; 1991 Jun; 75(6):340-1. PubMed ID: 2043575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of topical steroid therapy in the management of nonnecrotizing anterior scleritis.
    McMullen M; Kovarik G; Hodge WG
    Can J Ophthalmol; 1999 Jun; 34(4):217-21. PubMed ID: 10396658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indication and effect of immunosuppression in patients with scleritis].
    Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP
    Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis.
    Roufas A; Jalaludin B; Gaskin C; McCluskey P
    Br J Ophthalmol; 2010 Jun; 94(6):743-7. PubMed ID: 20447959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep intramuscular methylprednisolone treatment of recurrent scleritis.
    Deokule S; Saeed T; Murray PI
    Ocul Immunol Inflamm; 2005 Feb; 13(1):67-71. PubMed ID: 15804772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of therapeutic decision for scleritis.
    Sainz de la Maza M; Jabbur NS; Foster CS
    Ophthalmology; 1993 Sep; 100(9):1372-6. PubMed ID: 8371926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transeptal steroids in necrotizing scleritis].
    Sainz De La Maza Serra M; Folch Ramos J
    Arch Soc Esp Oftalmol; 2001 Oct; 76(10):589-92. PubMed ID: 11685675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleritis: presentations, disease associations and management.
    Sims J
    Postgrad Med J; 2012 Dec; 88(1046):713-8. PubMed ID: 22977282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and visual outcomes of Japanese patients with scleritis.
    Keino H; Watanabe T; Taki W; Nakashima C; Okada AA
    Br J Ophthalmol; 2010 Nov; 94(11):1459-63. PubMed ID: 20576778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial.
    O'Neil EC; Huang J; Suhler EB; Dunn JP; Perez VL; Gritz DC; McWilliams K; Peskin E; Ying GS; Bunya VY; Maguire MG; Kempen JH
    Br J Ophthalmol; 2018 Aug; 102(8):1011-1013. PubMed ID: 29666122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleritis, keratitis, and orbital cellulitis: isolated ocular manifestation of systemic lupus erythematosus.
    Lin WV; Saumur M; Al-Mohtaseb Z
    Lupus; 2018 Oct; 27(12):1985-1988. PubMed ID: 30092731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Episcleritis and scleritis.
    White GE
    Optom Clin; 1991; 1(4):79-87. PubMed ID: 1799838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Pharmacology for Scleritis: Review of Treatment and a Practical Perspective.
    Stem MS; Todorich B; Faia LJ
    J Ocul Pharmacol Ther; 2017 May; 33(4):240-246. PubMed ID: 28355124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Episcleritis and scleritis. An overview of modern diagnostic and therapeutic concepts].
    Denk PO; Thiel HJ; Zierhut M
    Klin Monbl Augenheilkd; 1997 Sep; 211(3):140-50. PubMed ID: 9445894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Orbital exenteration in therapy-resistant painful scleritis-associated inflammation of orbital soft tissues].
    Viestenz A; Colombo F; Holbach LM
    Klin Monbl Augenheilkd; 2002 Jun; 219(6):462-4. PubMed ID: 12136445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric-coated mycophenolate sodium as a corticosteroid-sparing agent for the treatment of autoimmune scleritis.
    Hwang YS; Chen HC; Chen KJ; Lai CC; Yeung L; Yang KJ; Lin KK; Hsiao CH
    Cornea; 2011 Mar; 30(3):260-4. PubMed ID: 21099416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of immunosuppressive agents in the treatment of necrotising scleritis: a retrospective, multicentre study in Korea.
    Jeon HS; Hyon JY; Kim MK; Chung TY; Yoon KC; Kim JY; Na KS; Kim HJ; Kim TI; Lee JS; Lee HK; Song JS
    Br J Ophthalmol; 2016 Aug; 100(8):1066-70. PubMed ID: 26598577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgically induced necrotising sclerokeratitis (SINS)--precipitating factors and response to treatment.
    O'Donoghue E; Lightman S; Tuft S; Watson P
    Br J Ophthalmol; 1992 Jan; 76(1):17-21. PubMed ID: 1739684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined orbital floor betamethasone and depot methylprednisolone in uveitis.
    Duguid IG; Ford RL; Horgan SE; Towler HM; Lightman SL
    Ocul Immunol Inflamm; 2005 Feb; 13(1):19-24. PubMed ID: 15804765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.